Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-03-27

Clinical Trial Update: A Prospective, Observational, Drug Utilization Study of Subjects Taking Truvada for Pre-exposure Prophylaxis in the USA

View source ↗

Summary

A completed prospective observational study evaluating the use of Truvada for HIV pre-exposure prophylaxis in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Gilead Sciences | Conditions: Pre-exposure Prophylaxis for Prevention of HIV Infection | Status: COMPLETED